Accuray Incorporated (FRA:XEJ)

Germany · Delayed Price · Currency is EUR

0.865

-0.005 (-0.57%)

At close: Dec 5, 2025

-56.09% (1Y)

Market Cap	99.13M
Revenue (ttm)	384.30M
Net Income (ttm)	-16.46M
Shares Out	n/a
EPS (ttm)	-0.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	3,553
Open	0.865
Previous Close	0.870
Day's Range	0.865 - 0.865
52-Week Range	0.810 - 2.540
Beta	n/a
RSI	35.95
Earnings Date	Jan 28, 2026

About Accuray

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidne... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus

Founded 1990

Employees 990

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol XEJ

Full Company Profile

Financial Performance

In 2025, Accuray's revenue was $458.51 million, an increase of 2.68% compared to the previous year's $446.55 million. Losses were -$1.59 million, -89.77% less than in 2024.

Financial numbers in USD Financial Statements

News

There is no news available yet.